Escalation of genome defense capacity enables control of an expanding meiotic driver
Abstract
From RNA interference to chromatin silencing, diverse genome defense pathways silence selfish genetic elements to safeguard genome integrity1,2. Despite their diversity, different defense pathways share a modular organization, where numerous specificity factors identify diverse targets and common effectors silence them. In the PIWI-interacting RNA (piRNA) pathway, which controls selfish elements in the metazoan germline, diverse target RNAs are first identified by complementary base pairing with piRNAs and then silenced by PIWI-clade nucleases via enzymatic cleavage1,3. Such a binary architecture allows the defense systems to be readily adaptable, where new targets can be captured via the innovation of new specificity factors4,5. Thus, our current understanding of genome defense against lineage-specific selfish genes has been largely limited to the evolution of specificity factors, while it remains poorly understood whether other types of innovations are required. Here, we describe a new type of innovation, which escalates the defense capacity of the piRNA pathway to control a recently expanded selfish gene in Drosophila melanogaster. Through an in vivo RNAi screen for repressors of Stellate—a recently evolved and expanded selfish meiotic driver6–8—we discovered a novel defense factor, Trailblazer. Trailblazer is a transcription factor that promotes the expression of two PIWI-clade nucleases, Aub and AGO3, to match Stellate in abundance. Recent innovation in the DNA-binding domain of Trailblazer enabled it to drastically elevate Aub and AGO3 expression in the D. melanogaster lineage, thereby escalating the silencing capacity of the piRNA pathway to control expanded Stellate and safeguard fertility. As copy-number expansion is a recurrent feature of diverse selfish genes across the tree of life9–12, we envision that augmenting the defense capacity to quantitatively match selfish genes is likely a repeatedly employed defense strategy in evolution.
Copyright and License
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Acknowledgement
We thank Andy Clark, Bruce Hay, Ching-Ho Chang, Ildar Gainetdinov, and Lu Yue for comments on the manuscript. We thank Ellen Rothenberg for discussion. We thank James McGehee and David Stern for advice on CRISPR/Cas9 in D. melanogaster and D. simulans, respectively. We thank Toshie Kai, Mayu Inaba, Bloomington Drosophila Stock Center, Vienna Drosophila Resource Center, and Kyoto Drosophila Stock Center for fly stocks. We are grateful to Elena Udartseva and Baira Godneeva for technical assistance. We appreciate the help of Igor Antoshechkin with sequencing, the help of Grace Shin with HCR, and the help of Giada Spigolon and Andres Collazo with microscopy.
Funding
National Institutes of Health, R01GM097363 (AAA)
Howard Hughes Medical Institute, Faculty Scholar Award (AAA)
National Institutes of Health, R35GM142494 (YCGL)
Contributions
Conceptualization: PC
Methodology: PC
Investigation: PC, KCP, EHP, YL, YCGL
Visualization: PC
Funding acquisition: AAA, YCGL
Project administration: PC, AAA
Supervision: PC, AAA
Writing – original draft: PC
Writing – review & editing: PC, KCP, EHP, YL, YCGL, AAA
Conflict of Interest
Authors declare that they have no competing interests.
Files
Name | Size | Download all |
---|---|---|
md5:043c55b2896384e9fab935dffd113386
|
894.9 kB | Preview Download |
Additional details
- PMCID
- PMC11195268
- National Institutes of Health
- R01GM097363
- Howard Hughes Medical Institute
- National Institutes of Health
- R35GM142494
- Caltech groups
- Division of Biology and Biological Engineering